Sessa William C
Department of Pharmacology, Boyer Center for Molecular Medicine, School of Medicine, Yale University, New Haven, CT 06536-0812, USA.
Mem Inst Oswaldo Cruz. 2005 Mar;100 Suppl 1:15-8. doi: 10.1590/s0074-02762005000900004. Epub 2005 Jun 14.
Endothelial nitric oxide synthase (eNOS) is the primary physiological source of nitric oxide (NO) that regulates cardiovascular homeostasis. Historically eNOS has been thought to be a constitutively expressed enzyme regulated by calcium and calmodulin. However, in the last five years it is clear that eNOS activity and NO release can be regulated by post-translational control mechanisms (fatty acid modification and phosphorylation) and protein-protein interactions (with caveolin-1 and heat shock protein 90) that direct impinge upon the duration and magnitude of NO release. This review will summarize this information and apply the post-translational control mechanisms to disease states.
内皮型一氧化氮合酶(eNOS)是调节心血管稳态的一氧化氮(NO)的主要生理来源。从历史上看,eNOS一直被认为是一种由钙和钙调蛋白调节的组成型表达酶。然而,在过去五年中,很明显eNOS的活性和NO释放可通过翻译后控制机制(脂肪酸修饰和磷酸化)以及蛋白质-蛋白质相互作用(与小窝蛋白-1和热休克蛋白90)来调节,这些机制直接影响NO释放的持续时间和幅度。本综述将总结这些信息,并将翻译后控制机制应用于疾病状态。